The results of the FCGR3B polymorphism were established for 148 SA patients (38 in Stage I, 60—Stage II, 35—Stage III, 21—Stage IV of SA), 179 TB patients and 154 healthy individuals. This evidence concerns the gene FCGR3B and tuberculosis.